Clinical Trial Update: Study of Temzolomide and Gleevec in Advanced Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating temzolomide and Gleevec in advanced melanoma has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Gleevec (Imatinib)
• Temzolomide (temzolomide)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Melanoma, Advanced Melanoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-03-30